SCHEMBL19851324

SCHEMBL19851324

Cc1cc(Cl)cc(C)c1C1=C(O)C2(CCC3(CC2)OCC(C)(C)CO3)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACACB O00763 11/20 0.44
ACACA Q13085 11/20 0.44
CES1 P23141 1/20 0.33
HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL229988 0.90 ACACB (0.45) ACACBACACACES1
SCHEMBL12362036 0.87 ACACB (0.43) ACACBACACACES1
SCHEMBL12362051 0.82 ACACB (0.41) ACACBACACACES1
SCHEMBL12362070 0.82 ACACB (0.39) ACACBACACA
SCHEMBL6113926 0.81 ACACB (0.71) ACACBACACA
SCHEMBL15472955 0.80 ACACB (0.47) ACACBACACACES1
SCHEMBL164823 0.80 ACACB (0.44) ACACBACACACES1
SCHEMBL15489227 0.80 ACACB (0.46) ACACBACACACES1
SCHEMBL12231707 0.79 ACACB (0.42) ACACBACACACES1
SCHEMBL19838173 0.79 ACACB (0.45) ACACBACACACES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494109-B1 PROCESS FOR THE PREPARATION OF SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AG (DE) 2024-10-23 EP disclosed
CN-109563066-B Process for preparing spiroketal-substituted cyclic ketoenols 拜耳作物科学股份公司 2023-08-29 CN disclosed
US-11220511-B2 Process for preparing spiroketal-substituted cyclic ketoenols BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2022-01-11 US disclosed
US-11220511-B2 Process for preparing spiroketal-substituted cyclic ketoenols BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2022-01-11 US disclosed
US-20190202837-A1 PROCESS FOR PREPARING SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-07-04 US disclosed
US-20190202837-A1 PROCESS FOR PREPARING SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-07-04 US disclosed
WO-2018024659-A1 METHOD FOR PRODUCING SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11220511-B2 Process for preparing spiroketal-substituted cyclic ketoenols AKR1C2, AKR1C4, AKR1C3 ACACB 144/4885ACACA 123/4885CES1 339/4885
US-20190202837-A1 PROCESS FOR PREPARING SPIROKETAL-SUBSTITUTED CYCLIC KETOENOLS AKR1C2, AKR1C4, AKR1C3 ACACB 144/4885ACACA 123/4885CES1 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.